National Research Corporation (OQ:NRC)

Sector:  Industrials Industry:  Business Support Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1245 Q St
LINCOLN NE 68508
Tel: N/A
Website: https://nrchealth.com
IR: See website
<
Key People
Michael D. Hays
President, Chief Executive Officer, Director 		Jason Hahn
Chief Revenue Officer 		Helen L. Hrdy
Chief Customer Officer
Christophe Louvion
Chief Product Technology Officer 		Andy Monnich
Chief Corporate Development Officer 		 
Business Overview
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.
Financial Overview
For the fiscal year ended 31 December 2023, National Research Corporation revenues decreased 2% to $148.6M. Net income applicable to common stockholders decreased 3% to $31M. Revenues reflect Canada segment decrease from $793K to $0K. Net income also reflects Impairment - Deferred Costs increase from $14M to $41M (expense), Depreciation and amortization increase of 12% to $5.9M (expense). Dividend per share decreased from $0.84 to $0.48.
Employees: 435 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $814.73M as of Dec 31, 2023
Annual revenue (TTM): $148.58M as of Dec 31, 2023
EBITDA (TTM): $86.95M as of Dec 31, 2023
Net annual income (TTM): $30.96M as of Dec 31, 2023
Free cash flow (TTM): -$14.03M as of Dec 31, 2023
Net Debt Last Fiscal Year: $30.07M as of Dec 31, 2023
Shares outstanding: 23,871,543 as of Mar 20, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More